Skip to content

Sonographic Detection of Prophylactic Pancreatic Stents

Sonographic Detection of Pancreatic Stents Placed for Prophylaxis of Post-ERCP Pancreatitis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03649399
Enrollment
41
Registered
2018-08-28
Start date
2018-03-01
Completion date
2020-04-21
Last updated
2020-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatitis, Stent Dislodgement

Brief summary

The Retention of pancreatic stents for prophylaxis of post-ERCP pancreatitis (PEP) is assessed by abdominal x-ray according to international Guidelines. The current study aimed to analyze whether prophylactic pancreatic stents can be detected by transdermal ultrasound to save the x-ray examination.

Detailed description

Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Several pharmacologic and procedure-related measurements have been established for post-ERCP pancreatitis (PEP) prophylaxis one being the placement of pancreatic duct stents in patients with high risk for PEP. The beneficial role of pancreatic stenting in the prophylaxis of PEP was demonstrated in large meta-analyses. The used stents have a high potential of self dislodgment, retained stents have to be removed endoscopically after 5-10 days. For evaluation of spontaneous stent passage abdominal x-ray ist used and accordingly retained stents removed. The current study aimed to analyze whether prophylactic pancreatic stents can be detected by transdermal ultrasound to save the x-ray examination.

Interventions

DIAGNOSTIC_TESTAbdominal ultrasound

Abdominal ultrasound for detection of the pancreatic stent

Sponsors

Johann Wolfgang Goethe University Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 79 Years
Healthy volunteers
No

Inclusion criteria

* patient after pancreatic stent placement for prophylaxis of post-ERCP pancreatitis * age 18-79 * signed informed consent

Exclusion criteria

* any disease that rules out study participation * patient not legally competent to sign informed consent * chronic pancreatis as indication for pancreatic stenting

Design outcomes

Primary

MeasureTime frameDescription
Positive predictive value of the sonographic detection of pancreatic stents5-10 days after stent placementTest whether the stents can be detected reliably by ultrasound

Secondary

MeasureTime frameDescription
Negative predictive value of the sonographic detection of pancreatic stents5-10 days after stent placementTest whether and why the stents cannot be detected reliably by ultrasound

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026